Total Payments
$8,078
2024 Payments
$950.00
Companies
42
Transactions
452
Medicare Patients
2,730
Medicare Billing
$158,050
Payment Breakdown by Category
Food & Beverage$8,063 (99.8%)
Education$15.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,063 | 450 | 99.8% |
| Education | $15.00 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,194 | 35 | $0 (2024) |
| Novo Nordisk Inc | $1,028 | 59 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $964.85 | 47 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $659.53 | 15 | $0 (2024) |
| AbbVie Inc. | $512.64 | 57 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $399.04 | 23 | $0 (2023) |
| PFIZER INC. | $353.14 | 23 | $0 (2024) |
| Amgen Inc. | $304.13 | 19 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $241.38 | 14 | $0 (2021) |
| Lilly USA, LLC | $231.72 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $950.00 | 22 | AstraZeneca Pharmaceuticals LP ($270.91) |
| 2023 | $954.61 | 50 | AstraZeneca Pharmaceuticals LP ($260.66) |
| 2022 | $1,301 | 93 | Janssen Pharmaceuticals, Inc ($231.10) |
| 2021 | $1,547 | 85 | Biohaven Pharmaceuticals, Inc. ($216.94) |
| 2020 | $742.48 | 47 | Novo Nordisk Inc ($188.17) |
| 2019 | $1,815 | 111 | AstraZeneca Pharmaceuticals LP ($316.88) |
| 2018 | $620.31 | 39 | Novo Nordisk Inc ($129.14) |
| 2017 | $147.50 | 5 | Novo Nordisk Inc ($86.78) |
All Payment Transactions
452 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | Imperative Care, Inc | SYMPHONY CATHETER (Device) | Food and Beverage | In-kind items and services | $36.91 | General |
| Category: VASCULAR | ||||||
| 11/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $8.56 | General |
| Category: Respiratory | ||||||
| 10/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $87.22 | General |
| Category: DIABETES | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: RESPIRATORY | ||||||
| 10/14/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: VACCINES | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Endocrinology | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $121.35 | General |
| Category: Respiratory | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $110.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/28/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: VACCINES | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/24/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: VACCINES | ||||||
| 04/02/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $146.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/20/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.37 | General |
| 02/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: VACCINES | ||||||
| 02/22/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $64.91 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $123.97 | General |
| 01/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: Oncology | ||||||
| 12/21/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Diabetes Care | ||||||
| 12/04/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: VACCINES | ||||||
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $121.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 589 | 697 | $106,176 | $32,361 |
| 2022 | 12 | 600 | 719 | $111,312 | $32,682 |
| 2021 | 15 | 702 | 850 | $124,676 | $33,213 |
| 2020 | 18 | 839 | 1,008 | $127,670 | $59,793 |
Total Patients
2,730
Total Services
3,274
Medicare Billing
$158,050
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 122 | 172 | $23,048 | $6,632 | 28.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 108 | 154 | $29,414 | $6,098 | 20.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 21 | 21 | $7,560 | $5,921 | 78.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 119 | 119 | $25,585 | $4,915 | 19.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 63 | 66 | $8,646 | $4,824 | 55.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 67 | 69 | $3,243 | $2,026 | 62.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 14 | 14 | $3,864 | $856.43 | 22.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 21 | 21 | $987.00 | $616.56 | 62.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 17 | 17 | $2,856 | $247.67 | 8.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 19 | $798.00 | $138.42 | 17.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 21 | 25 | $175.00 | $85.25 | 48.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 137 | 193 | $36,863 | $8,328 | 22.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 109 | 157 | $21,038 | $6,526 | 31.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 23 | 23 | $7,080 | $5,979 | 84.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 108 | 108 | $23,365 | $4,636 | 19.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 40 | 43 | $5,628 | $2,994 | 53.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 24 | 24 | $6,624 | $1,551 | 23.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 43 | 46 | $2,162 | $1,290 | 59.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 25 | 25 | $1,175 | $702.13 | 59.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 37 | 37 | $6,216 | $295.95 | 4.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 15 | 15 | $525.00 | $142.38 | 27.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 28 | 36 | $252.00 | $123.47 | 49.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 11 | 12 | $384.00 | $115.26 | 30.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 159 | 230 | $43,482 | $11,146 | 25.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 138 | 202 | $26,993 | $8,507 | 31.5% |
About Dr. Emmett Roper, M.D
Dr. Emmett Roper, M.D is a Internal Medicine healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518926344.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Emmett Roper, M.D has received a total of $8,078 in payments from pharmaceutical and medical device companies, with $950.00 received in 2024. These payments were reported across 452 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($8,063).
As a Medicare-enrolled provider, Roper has provided services to 2,730 Medicare beneficiaries, totaling 3,274 services with total Medicare billing of $158,050. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Cincinnati, OH
- Active Since 03/21/2006
- Last Updated 10/16/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1518926344
Products in Payments
- XARELTO (Drug) $942.65
- FARXIGA (Drug) $786.06
- Ozempic (Drug) $525.04
- NURTEC ODT (Drug) $389.59
- JARDIANCE (Drug) $383.79
- VRAYLAR (Drug) $333.60
- ENTRESTO (Drug) $323.67
- UBRELVY (Drug) $184.10
- Aimovig (Biological) $150.09
- BREZTRI (Drug) $149.18
- Saxenda (Drug) $146.51
- InPen (Device) $141.65
- FREESTYLE LIBRE (Device) $135.70
- Victoza (Drug) $126.18
- AIRSUPRA (Drug) $121.35
- RYBELSUS (Drug) $119.39
- QULIPTA (Drug) $107.12
- KRYSTEXXA (Biological) $105.51
- PREVNAR 20 (Biological) $91.19
- SOLIQUA (Drug) $87.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cincinnati
Jonathan Bernstein, Md, MD
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Nelson Watts, M.d, M.D
Internal Medicine — Payments: $788,194
Internal Medicine $788,194
Robert Baughman, M.d, M.D
Internal Medicine — Payments: $766,919
Internal Medicine $766,919
Mark Andolina, Md, MD
Internal Medicine — Payments: $469,821
Internal Medicine $469,821
Amit Govil, M.d, M.D
Internal Medicine — Payments: $410,360
Internal Medicine $410,360
Vincent Martin, Md, MD
Internal Medicine — Payments: $332,673
Internal Medicine $332,673